Geared Power BioTech CEO discusses BioGuard UVC on podcast

Geared Power BioTech founder and CEO Gary Kellstrom, Jr. appeared on the “Going Beyond the Deal” podcast to discuss the company’s BioGuard UVC wearable and the journey behind its development. The episode highlights the startup’s pitch that a filter-less, UV-based source-control mask could help reduce the spread of respiratory disease in healthcare settings.

Why it matters: - Geared Power BioTech is trying to commercialize BioGuard UVC™, a wearable device aimed at stopping the spread of respiratory disease in hospitals and emergency response settings. - The company is positioning the product as a potential public-health tool for inactivating airborne pathogens in exhaled breath in real time. - The podcast appearance gives the New Jersey startup a broader platform as it tries to build awareness around a still-emerging medtech product.

What happened: - Geared Power BioTech said founder and CEO Gary Kellstrom, Jr. was featured on the “Going Beyond the Deal” podcast hosted by J. Michael Fischer, Jr. - The episode is now available worldwide. - The conversation focused on Kellstrom’s entrepreneurial path, the company’s pivot from an automotive transmission prototype to a pandemic-era mask, and the buildout of BioGuard UVC™. - The release said the discussion also covered the challenges of commercializing innovative medical technology and New Jersey’s innovation ecosystem.

The details: - BioGuard UVC™ is described as a filter-less source-control mask with helical UV chambers. - Geared Power BioTech says the device is intended to help stop the spread of respiratory disease by attacking the source. - The company says the technology could help prevent future pandemics by inactivating airborne pathogens in exhaled breath of infected individuals in real time. - Kellstrom called the conversation “genuine” and said he was grateful for the chance to share the story behind BioGuard UVC™. - Fischer said the episode shows “what conviction looks like before the win is guaranteed.” - The episode is available on Apple Podcasts, Spotify and YouTube. - The release includes a company website, More information, and a social link, LinkedIn showcase.

Between the lines: - The release reads like a mix of podcast promotion and startup positioning, with the company using the appearance to frame BioGuard UVC™ as a high-conviction medtech bet. - The strongest claim is forward-looking: the device could help prevent future pandemics. That remains an ambition, not a demonstrated outcome. - The New Jersey tie-in suggests Geared Power BioTech is leaning on local innovation networks as it seeks credibility and traction.

What's next: - Geared Power BioTech is encouraging listeners to subscribe and follow the podcast. - The company appears to be continuing its push to commercialize BioGuard UVC™ for healthcare facilities and emergency response use. - Additional product development, validation and adoption milestones will likely determine whether the device moves beyond a founder story into broad clinical use.

The bottom line: - Geared Power BioTech is using a podcast appearance to spotlight a bold claim: a filter-less wearable mask with UV chambers could become a new tool against respiratory disease.